Business Context and Reporting Period
Company: Adial Pharmaceuticals, Inc. (ADIL)
Filing Type: Form 8-K (Current Report)
Report Date: August 21, 2023
Reporting Period: Fiscal quarter ended June 30, 2023
Business Context: The Company is a Delaware corporation and an emerging growth company. This filing serves to announce the issuance of a press release containing financial information for the second quarter of 2023.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data points. It references a press release (Exhibit 99.1) where the actual figures are located.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms that financial information for the quarter ended June 30, 2023, has been released.
Guidance, Outlook, and Risks
Management Commentary: The filing states that the press release attached as Exhibit 99.1 includes financial information. No specific outlook or commentary is included in the 8-K text itself.
Legal Disclaimer: The information in Item 2.02 and the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any other SEC filings.
Risks and Contingencies: No specific risks or contingencies are detailed in this document.
Investor Verification Checklist
- Review Exhibit 99.1 (the Press Release) to obtain actual revenue, net loss, and cash position figures for the quarter ended June 30, 2023.
- Verify the Company's status as an emerging growth company and its implications for financial reporting standards.
- Confirm trading symbols ADIL (Common Stock) and ADILW (Warrants) on the Nasdaq Capital Market.
- Note that the financial data in this 8-K is not incorporated by reference into future filings.